New Drug for Meniere’s Disease? Clinical trials starting soon.
According to a press release from Sound Pharmaceuticals (SPI) on January 5th 2016, new trials are set to begin to test the drug SPI-1005 for Meniere’s Disease.
SPI-1005 is an investigational drug that contains an orally available small molecule that mimics and induces Glutathione Peroxidase (GPx) activity. GPx1 activity is diminished after ototoxic insults that cause sensorineural hearing loss and tinnitus.
In pre-clinical studies, SPI-1005 has been shown to prevent and treat different types of hearing loss that involve auditory hair cells and neurons. In a recent Phase 2 clinical study, SPI-1005 was shown to prevent sensorineural hearing loss due to noise.
“Based on the anti-inflammatory activity of SPI-1005, we hope that it will be of benefit in Meniere’s disease,” said Jonathan Kil, MD, CEO.
It is interesting that the focus of this study is based on the “anti-inflammatory” properties of this drug. We at Menieres-Help.Com and others around the world have been focused on dealing with the inflammation within the ear for over 12 years.To understand why inflammation is so important to Meniere’s sufferers click here.
The difference is we concentrate on allowing the body to deal with the inflammation naturally by making sure the immune system is healthy and strong enough to do so. A healthy organic wholefood diet supported by quality nutritional supplements has been successful in allowing sufferers to reduce their symptoms significantly for well over a decade.
In addition, this method results in general health being much better and there are no possibilities of any side effects from synthetic drugs occurring over time.
Moreover, and more importantly our approach has been to identify and deal with the root cause(s) of the inflammation causing the symptoms and to eliminate that cause from our life. Learn more about this by clicking here.
Any trials that may benefit Meniere’s sufferers are always welcome but as always it seems the focus is to “treat” the symptoms rather than find the cure by identifying the root cause. This is the plight plaguing the medical world and therefore patients in a corporate profit driven society. Find the root cause and eliminate it and it is game over but by treating conditions with drugs the big corporate pharmaceutical drug manufacturers get recurring income from millions of prescriptions that can be continued for decades if not the rest of a patient’s life depending on the condition.
Quite simply and to be brutally honest, there is no money in finding cures even though cures for many conditions are available, almost all of which are natural and drive from common sense, understanding how the body works and the importance of what we eat and do not eat, our environment, metabolism and internal organ health and muscular skeletal condition.
Betahistine For Meniere’s Disease – Efficacy and Safety Study
Table of Contents
Can Betahistine stop vertigo in Meniere’s Disease?
Betahistine is a very common drug used to “treat” Meniere’s Disease. A new paper was published online in January 2016 on the long term effectiveness and safety of using the drug. The study was supported by grants from the German Federal Ministry of Education and Research.
Having suffered with Meniere’s Disease for seven years (and beating it), having used Betahistine, supporting Meniere’s sufferers for 12 years and researching triggers and root causes for 7 years, I have to say the effectiveness of this drug in my view is very questionable at best. Anyone who has read through Menieres-Help.Com will know we view the drugs used to treat Meniere’s with a LOT of skepticism. This is born out of our own experience and the experiences of thousands of people who have contacted us over the years.
It is our view based on experience and again, thousands of testimonials, that by supporting your immune system through a healthy, organic, wholefood diet and quality supplements you can live symptom free and moreover, by finding and dealing with your root cause (there are several possibilities here) you can give yourself more of a chance of living a normal life again
“Treatments” are only focusing on the “symptoms”, which are a result of the root cause and knock on effects throughout the body. Treating the symptoms can go on for decades with little to no success and cost a lot of money.
Do you really want to spend another 10, 15, 20 years or the rest of your life living with the horrendous effects of Meniere’s and spend a fortune in the meantime on useless or questionable drug treatments?
We have received emails from people who had lived with these symptoms for up to 30 years and nothing had helped, only to find they could have rid themselves naturally all along. Make no mistake you CAN get your life back. It is just a matter of informing yourself and taking appropriate action.
By letting your body deal with the problem efficiently through a comprehensive, healthy, strong immune system and eliminating the root cause(s) you will can rid yourself of Meniere’s forever and it will take a LOT less time and money.
The added bonus of this route is that there are no concerns for the long term effects of synthetic drugs being pumped into your body. Long term use of some drugs used to treat Meniere’s can actually cause some of the same symptoms.
Read through Menieres-Help.Com for information related to all this and Click Here to learn more about how you can free yourself of Meniere’s forever.
That aside we try to give as wide and comprehensive information on all things related to Meniere’s, so below is a summary of the study. Note in the abstract the author states “Current evidence is limited as to whether betahistine prevents vertigo attacks.“
I am sure you will agree if you suffer from Meniere’s that the vertigo is the worst of the many debilitating symptoms of this condition.
Study
Abstract
Study question What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients with Meniere’s disease, compared with placebo?
Methods The BEMED trial is a multicentre, double blind, randomised, placebo controlled, three arm, parallel group, phase III, dose defining superiority trial conducted in 14 German tertiary referral centres (for neurology or ear, nose, and throat). Adults aged 21-80 years (mean age 56 years) with definite unilateral or bilateral Meniere’s disease were recruited from March 2008 to November 2012. Participants received placebo (n=74), low dose betahistine (2×24 mg daily, (n=73)), or high dose betahistine (3×48 mg daily, (n=74)) over nine months. The primary outcome was the number of attacks per 30 days, based on patients’ diaries during a three month assessment period at months seven to nine. An internet based randomisation schedule performed a concealed 1:1:1 allocation, stratified by study site. Secondary outcomes included the duration and severity of attacks, change in quality of life scores, and several observer-reported parameters to assess changes in audiological and vestibular function.
Study answer and limitations Incidence of attacks related to Meniere’s disease did not differ between the three treatment groups (P=0.759). Compared with placebo, attack rate ratios were 1.036 (95% confidence interval 0.942 to 1.140) and 1.012 (0.919 to 1.114) for low dose and high dose betahistine, respectively. The overall monthly attack rate fell significantly by the factor 0.758 (0.705 to 0.816; P<0.001). The population based, mean monthly incidence averaged over the assessment period was 2.722 (1.304 to 6.309), 3.204 (1.345 to 7.929), and 3.258 (1.685 to 7.266) for the placebo, low dose betahistine, and high dose betahistine groups, respectively. Results were consistent for all secondary outcomes. Treatment was well tolerated with no unexpected safety findings. Without a control group of patients who did not receive any intervention to follow the natural course of the disease, the placebo effect could not be accurately assessed and differentiated from spontaneous remission and fluctuation of symptoms.
What this study adds Current evidence is limited as to whether betahistine prevents vertigo attacks caused by Meniere’s disease, compared with placebo. The trial provides information on symptom relief on placebo intervention which is relevant for the design of future studies on potential disease modifying treatments in patients with Meniere’s disease.
Conclusion
So is Betahistine For Meniere’s Disease the best way to go? That is for you and your treating health professional to decide. There are many options available to you. Betahistine is commonly prescribed and some say it helps. In my case it didn’t. Anything that reduces vertigo is welcome to the Meniere’s sufferer but as alluded to above, there are many ways to eliminate your vertigo.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
